Skip to main content
. 2010 Sep 27;10:27. doi: 10.1186/1471-2482-10-27

Table 5.

Effect of peri-operative chemotherapy on survival for metachronous synchronous CRCLM

Number of patients 3-year survival rate (%) 5-year survival rate (%) Univariate P-value
Chemotherapy before hepatectomy
Present 3 33.3 0 0.2267
Absent 25 66.0 66.0

Chemotherapy after hepatectomy
Present 20 76.5 76.5 0.0458
Absent 7 0 0